Results 81 to 90 of about 830,673 (331)
Peritoneal metastases portend poor prognosis in the setting of standard chemotherapy. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) improves outcomes, but relapse is common.
R. Ramanathan +6 more
semanticscholar +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou +4 more
wiley +1 more source
Correction to: Peritoneal Metastases in Colorectal Cancer [PDF]
In the original article Fadi Dahdaleh's last name was spelled incorrectly. It is correct as reflected here.
Richard, Jacobson +3 more
openaire +2 more sources
The investigation of pressurised intraperitoneal aerosolised therapeutics for peritoneal metastases [PDF]
Peritoneal metastases are a feature of many cancers. Cancer surveillance statistics in the UK do not record the incidence of specific metastatic locations so it is not possible to define the overall burden of disease.
Tate, Sophia
core +6 more sources
Background: Pancreatic ductal adenocarcinoma (PDAC) often presents with liver or peritoneal metastases at diagnosis. Despite similar treatment approaches, patient outcomes vary between these metastatic sites.
Guoliang Yao +10 more
doaj +1 more source
The therapeutic potential of immune checkpoint inhibitors is currently being investigated in epithelial ovarian cancer (EOC), but immunological effects of the programmed cell death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) axis in EOC ...
Christine Bekos +8 more
semanticscholar +1 more source
Value of procollagen type I aminoterminal propeptide in women with breast cancer with regard to metastases [PDF]
Background. The aim of this study was to show the importance of the bone marker procollagen type 1 aminoterminal propeptide (P1NP) in detecting bone metastases in women suffering from breast cancer.
Oremek, Gerhard +3 more
core +1 more source
Integrative multi‐omics analysis delineates a mitochondrial–immune axis governing neoadjuvant chemotherapy response in high‐grade serous ovarian cancer. Immune‐active tumors exhibit enhanced B‐cell infiltration and favorable sensitivity, whereas metabolically rewired tumors display oxidative phosphorylation dependency and resistance.
Wei Jiang +11 more
wiley +1 more source
Peritoneal metastases carry the worst prognosis among all sites of colorectal cancer (CRC) metastases. In recent years, the advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival for selected ...
F. Rosa +7 more
semanticscholar +1 more source

